# reload+after+2024-01-23 14:31:13.692853
address1§6555 State Highway 161
city§Irving
state§TX
zip§75039
country§United States
phone§972 446 4800
website§https://www.mckesson.com
industry§Medical Distribution
sector§Healthcare
longBusinessSummary§McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
fullTimeEmployees§45000
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Brian S. Tyler Ph.D.', 'age': 56, 'title': 'CEO & Director', 'yearBorn': 1967, 'fiscalYear': 2023, 'totalPay': 7220729, 'exercisedValue': 6332017, 'unexercisedValue': 16181724}, {'maxAge': 1, 'name': 'Mr. Britt J. Vitalone', 'age': 54, 'title': 'Executive VP & CFO', 'yearBorn': 1969, 'fiscalYear': 2023, 'totalPay': 3037005, 'exercisedValue': 1101388, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. LeAnn B. Smith', 'age': 48, 'title': 'Executive VP & Chief Human Resources Officer', 'yearBorn': 1975, 'fiscalYear': 2023, 'totalPay': 1324695, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Lori A. Schechter J.D.', 'age': 61, 'title': 'Board & Enterprise Risk Advisor', 'yearBorn': 1962, 'fiscalYear': 2023, 'totalPay': 2604906, 'exercisedValue': 1022195, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Napoleon B. Rutledge Jr.', 'age': 51, 'title': 'Senior VP, Controller & Chief Accounting Officer', 'yearBorn': 1972, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Francisco  Fraga', 'age': 50, 'title': 'Executive VP, Chief Information Officer & Chief Technology Officer', 'yearBorn': 1973, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Rachel  Rodriguez', 'title': 'Vice President of Investor Relations', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Michele  Lau', 'age': 46, 'title': 'Executive VP & Chief Legal Officer', 'yearBorn': 1977, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Pete  Slone', 'title': 'Senior Vice President of Corporate Public Affairs', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kirk  Kaminsky', 'title': 'President of The US Pharmaceutical & Specialty Solutions Business', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§8
boardRisk§1
compensationRisk§4
shareHolderRightsRisk§4
overallRisk§2
governanceEpochDate§1704067200
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§2
dividendRate§2.48
dividendYield§0.0052
exDividendDate§1701302400
payoutRatio§0.088599995
fiveYearAvgDividendYield§0.85
beta§0.479
priceToSalesTrailing12Months§0.21858247
currency§USD
dateShortInterest§1702598400
forwardEps§30.8
pegRatio§1.79
exchange§NYQ
quoteType§EQUITY
shortName§McKesson Corporation
longName§McKesson Corporation
firstTradeDateEpochUtc§784477800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§0e65924a-76f6-3886-8304-25672766d519
gmtOffSetMilliseconds§-18000000
targetHighPrice§563.0
targetLowPrice§450.0
targetMeanPrice§511.14
targetMedianPrice§514.5
recommendationMean§1.9
recommendationKey§buy
numberOfAnalystOpinions§14
quickRatio§0.489
earningsGrowth§-0.233
grossMargins§0.04192
ebitdaMargins§0.01682
trailingPegRatio§5.0038
